$PCT
PureCycle Technologies, Inc. Stock $pct

$pct Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000183003322000059 Filed on November 09, 2022

Income Statement

Concept	2022 Q4	2022 Q3
Revenue	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$11.59M	$14.38M
YoY Change	-36.49%	-41.27%
% of Gross Profit
Research & Development	$247.0K	$254.0K
YoY Change	-20.32%	-23.03%
% of Gross Profit
Depreciation & Amortization	$1.030M	$900.0K
YoY Change	33.07%	72.41%
% of Gross Profit
Operating Expenses	$21.44M	$21.09M
YoY Change	-1.99%	-23.34%
Operating Profit
YoY Change
Interest Expense	$1.807M	$1.102M
YoY Change	-294.3%	-40.21%
% of Operating Profit
Other Income/Expense, Net	$10.28M	-$13.86M
YoY Change	200.7%	-312.3%
Pretax Income	-$9.362M	-$34.95M
YoY Change	-51.72%	66.6%
Income Tax
% Of Pretax Income
Net Earnings	-$9.362M	-$34.95M
YoY Change	-51.72%	66.6%
Net Earnings / Revenue
Basic Earnings Per Share		-$0.21
Diluted Earnings Per Share	-$0.06	-$0.21
COMMON SHARES
Basic Shares Outstanding	163.5M shares	163.5M shares
Diluted Shares Outstanding		163.5M shares

Balance Sheet

Concept	2022 Q4	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$162.5M	$215.0M
YoY Change	-19.07%	-2.85%
Cash & Equivalents	$63.89M	$56.45M
Short-Term Investments	$98.59M	$158.5M
Other Short-Term Assets	$73.73M	$106.1M
YoY Change	-49.0%	3698.07%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$236.2M	$321.0M
YoY Change	-31.6%	43.3%
LONG-TERM ASSETS
Property, Plant & Equipment	$505.7M	$438.6M
YoY Change	124.55%	131.78%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$100.3M	$107.9M
YoY Change	6.53%	-61.3%
Total Long-Term Assets	$625.1M	$566.0M
YoY Change	95.76%	20.97%
TOTAL ASSETS
Total Short-Term Assets	$236.2M	$321.0M
Total Long-Term Assets	$625.1M	$566.0M
Total Assets	$861.3M	$887.1M
YoY Change	29.59%	28.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.667M	$7.100M
YoY Change	18.99%	240.69%
Accrued Expenses	$35.10M	$32.57M
YoY Change	-1.19%	-26.62%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00
YoY Change
Total Short-Term Liabilities	$38.30M	$45.80M
YoY Change	-0.41%	-15.61%
LONG-TERM LIABILITIES
Long-Term Debt	$233.5M	$233.3M
YoY Change	0.43%	-20.1%
Other Long-Term Liabilities	$1.136M	$1.108M
YoY Change	6.27%	2.97%
Total Long-Term Liabilities	$234.6M	$1.108M
YoY Change	21850.33%	2.97%
TOTAL LIABILITIES
Total Short-Term Liabilities	$38.30M	$45.80M
Total Long-Term Liabilities	$234.6M	$1.108M
Total Liabilities	$350.5M	$368.6M
YoY Change	23.77%	1.86%
SHAREHOLDERS EQUITY
Retained Earnings	-$242.5M	-$233.2M
YoY Change	53.71%	68.47%
Common Stock	$164.0K	$164.0K
YoY Change	28.13%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$510.9M	$518.5M
YoY Change
Total Liabilities & Shareholders Equity	$861.3M	$887.1M
YoY Change	29.59%	28.2%

Cashflow Statement

Concept	2022 Q4	2022 Q3
OPERATING ACTIVITIES
Net Income	-$9.362M	-$34.95M
YoY Change	-51.72%	66.6%
Depreciation, Depletion And Amortization	$1.030M	$900.0K
YoY Change	33.07%	72.41%
Cash From Operating Activities	-$15.31M	-$15.07M
YoY Change	22.03%	108.2%
INVESTING ACTIVITIES
Capital Expenditures	$75.09M	-$85.03M
YoY Change	-252.52%	125.78%
Acquisitions
YoY Change
Other Investing Activities	$60.50M	$73.09M
YoY Change	260.15%	365.03%
Cash From Investing Activities	-$14.59M	-$11.94M
YoY Change	-55.01%	-45.59%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-88.00K	-518.0K
YoY Change	-87.57%	-423.75%
NET CHANGE
Cash From Operating Activities	-15.31M	-15.07M
Cash From Investing Activities	-14.59M	-11.94M
Cash From Financing Activities	-88.00K	-518.0K
Net Change In Cash	-29.99M	-27.53M
YoY Change	-34.36%	-5.14%
FREE CASH FLOW
Cash From Operating Activities	-$15.31M	-$15.07M
Capital Expenditures	$75.09M	-$85.03M
Free Cash Flow	-$90.41M	$69.95M
YoY Change	-346.44%	129.96%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity Central Index Key EntityCentralIndexKey	0001830033
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
CY2020	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2022#AccountingStandardsUpdate202006Member
CY2021Q1	pct	Derivative Instrument Contingent Consideration Liability Earnout Period Business Days Prior To Notice Of Redemption DerivativeInstrumentContingentConsiderationLiabilityEarnoutPeriodBusinessDaysPriorToNoticeOfRedemption	P3D
CY2022Q3	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-40234
	dei	Entity Registrant Name EntityRegistrantName	PureCycle Technologies, Inc.
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	86-2293091
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Address Address Line1 EntityAddressAddressLine1	5950 Hazeltine National Drive,
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 300
	dei	Entity Address City Or Town EntityAddressCityOrTown	Orlando
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	32822
	dei	City Area Code CityAreaCode	877
	dei	Local Phone Number LocalPhoneNumber	648-3565
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	163506449	shares
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	56447000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	33417000	usd
CY2022Q3	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	158513000	usd
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	167365000	usd
CY2022Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	100048000	usd
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	141855000	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6032000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2712000	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	321040000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	345349000	usd
CY2022Q3	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	101023000	usd
CY2021Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	88586000	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	6831000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	5535000	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	19607000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	0	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	438586000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	225214000	usd
CY2022Q3	us-gaap	Assets Assets	887087000	usd
CY2021Q4	us-gaap	Assets Assets	664684000	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	7100000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1401000	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	32570000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	35526000	usd
CY2022Q3	us-gaap	Interest Payable Current InterestPayableCurrent	6127000	usd
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	1532000	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	45797000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	38459000	usd
CY2022Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	5000000	usd
CY2021Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	5000000	usd
CY2022Q3	us-gaap	Long Term Loans Payable LongTermLoansPayable	233254000	usd
CY2021Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	232508000	usd
CY2022Q3	pct	Warrant Liability Noncurrent WarrantLiabilityNoncurrent	66265000	usd
CY2021Q4	pct	Warrant Liability Noncurrent WarrantLiabilityNoncurrent	6113000	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	17126000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	usd
CY2022Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1108000	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1069000	usd
CY2022Q3	us-gaap	Liabilities Liabilities	368550000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	283149000	usd
CY2022Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	163509000	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	163509000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	127647000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	127647000	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	164000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	128000	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	752559000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	539423000	usd
CY2022Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1023000	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-237000	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-233163000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-157779000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	518537000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	381535000	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	887087000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	664684000	usd
CY2022Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	6451000	usd
CY2021Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	2687000	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	16948000	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	7228000	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	254000	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	330000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	843000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1101000	usd
CY2022Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	14382000	usd
CY2021Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	24489000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	42083000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	39372000	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	21087000	usd
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	27506000	usd
	us-gaap	Operating Expenses OperatingExpenses	59874000	usd
	us-gaap	Operating Expenses OperatingExpenses	47701000	usd
CY2022Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	1102000	usd
CY2021Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-1843000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	834000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-5722000	usd
CY2022Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	14884000	usd
CY2021Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-8369000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	16224000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	4893000	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-79000	usd
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-120000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	206000	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-13861000	usd
CY2021Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	6529000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-15510000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-10409000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-34948000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-20977000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-75384000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-58110000	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.21
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.21
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.18
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.49
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.49
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.61
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.61
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	163490000	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	163490000	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	118255000	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	118255000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	153513000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	153513000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	95773000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	95773000	shares
CY2022Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	14000	usd
CY2021Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	89000	usd
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-800000	usd
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-17000	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-34934000	usd
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-20888000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-76184000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-58127000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	381535000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	205296000	usd
CY2022Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	1049000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3171000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-340000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-25432000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	563181000	usd
CY2022Q2	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	17000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3267000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-460000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-15004000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	550967000	usd
CY2022Q3	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	506000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3010000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	14000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-34948000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	518537000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	111749000	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	239000	usd
CY2021Q1	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	36000	usd
CY2021Q1	pct	Stock Issued During Period Value Reverse Recapitalization StockIssuedDuringPeriodValueReverseRecapitalization	0	usd
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	28000000	usd
CY2021Q1	pct	Stock Issued During Period Value Reverse Recapitalization Net Of Redemptions And Issuance Costs StockIssuedDuringPeriodValueReverseRecapitalizationNetOfRedemptionsAndIssuanceCosts	293966000	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures	0	usd
CY2021Q1	pct	Stock Reclassified During Period Value StockReclassifiedDuringPeriodValue	33000	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	68000	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-26074000	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	349241000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	835000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-106000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-11059000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	338911000	usd
CY2021Q3	pct	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	196000	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	13611000	usd
CY2021Q3	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	1695000	usd
CY2021Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	89000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-20977000	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	330135000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-75384000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-58110000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	9448000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	14753000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	16224000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	4893000	usd
	us-gaap	Depreciation Depreciation	2583000	usd
	us-gaap	Depreciation Depreciation	1507000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	746000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2208000	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	235000	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-395000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	964000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	0	usd
	pct	Issuance Of Warrants Costs IssuanceOfWarrantsCosts	0	usd
	pct	Issuance Of Warrants Costs IssuanceOfWarrantsCosts	109000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	314000	usd
	pct	Increase Decrease In Prepaid Expenses And Other Assets Current IncreaseDecreaseInPrepaidExpensesAndOtherAssetsCurrent	3320000	usd
	pct	Increase Decrease In Prepaid Expenses And Other Assets Current IncreaseDecreaseInPrepaidExpensesAndOtherAssetsCurrent	2347000	usd
	pct	Increase Decrease In Prepaid Expenses And Other Assets Noncurrent IncreaseDecreaseInPrepaidExpensesAndOtherAssetsNoncurrent	1296000	usd
	pct	Increase Decrease In Prepaid Expenses And Other Assets Noncurrent IncreaseDecreaseInPrepaidExpensesAndOtherAssetsNoncurrent	2917000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	827000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-399000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	491000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-9554000	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	324000	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	2819000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	0	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	5000000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1536000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	0	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-50164000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-41957000	usd
	us-gaap	Payments For Construction In Process PaymentsForConstructionInProcess	212095000	usd
	us-gaap	Payments For Construction In Process PaymentsForConstructionInProcess	88153000	usd
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	192388000	usd
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	229183000	usd
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	200689000	usd
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	44197000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-203794000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-273139000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	206072000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	43929000	usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	0	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1572000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	775000	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-36000	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	160000	usd
	pct	Proceeds From Reverse Recapitalization ProceedsFromReverseRecapitalization	0	usd
	pct	Proceeds From Reverse Recapitalization ProceedsFromReverseRecapitalization	298461000	usd
	pct	Payments Of Notes Issuance Costs PaymentsOfNotesIssuanceCosts	0	usd
	pct	Payments Of Notes Issuance Costs PaymentsOfNotesIssuanceCosts	4067000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	480000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	247618000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	294074000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-6340000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-21022000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	263858000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	330574000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	257518000	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	309552000	usd
	us-gaap	Interest Paid Net InterestPaidNet	650000	usd
	us-gaap	Interest Paid Net InterestPaidNet	845000	usd
	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	22059000	usd
	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	25300000	usd
	pct	Construction In Progress Expenditures Accrued For But Not Yet Paid ConstructionInProgressExpendituresAccruedForButNotYetPaid	3267000	usd
	pct	Construction In Progress Expenditures Accrued For But Not Yet Paid ConstructionInProgressExpendituresAccruedForButNotYetPaid	1425000	usd
	pct	Construction In Progress Expenditures Owed But Not Yet Paid ConstructionInProgressExpendituresOwedButNotYetPaid	4271000	usd
	pct	Construction In Progress Expenditures Owed But Not Yet Paid ConstructionInProgressExpendituresOwedButNotYetPaid	1708000	usd
	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	0	usd
	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	4604000	usd
	pct	Share Repurchase Additions To Accrued Expense Noncash Activities ShareRepurchaseAdditionsToAccruedExpenseNoncashActivities	0	usd
	pct	Share Repurchase Additions To Accrued Expense Noncash Activities ShareRepurchaseAdditionsToAccruedExpenseNoncashActivities	1695000	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	0	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	1680000	usd
CY2022Q1	pct	Business Combination Acquisition Related Costs Advisory Legal And Accounting BusinessCombinationAcquisitionRelatedCostsAdvisoryLegalAndAccounting	800000	usd
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain amounts in prior periods have been reclassified to conform with the report classifications of the nine months ended September 30, 2022 and 2021.</span></div>
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	56447000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	33417000	usd
CY2022Q3	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	158513000	usd
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	167365000	usd
CY2022Q3	pct	Unrestricted Liquidity Amount UnrestrictedLiquidityAmount	214960000	usd
CY2021Q4	pct	Unrestricted Liquidity Amount UnrestrictedLiquidityAmount	200782000	usd
CY2022Q3	pct	Other Facility Set Aside Amount OtherFacilitySetAsideAmount	54560000	usd
CY2021Q4	pct	Other Facility Set Aside Amount OtherFacilitySetAsideAmount	50713000	usd
CY2022Q3	pct	Available Unrestricted Liquidity Amount AvailableUnrestrictedLiquidityAmount	160400000	usd
CY2021Q4	pct	Available Unrestricted Liquidity Amount AvailableUnrestrictedLiquidityAmount	150069000	usd
CY2022Q3	us-gaap	Restricted Cash RestrictedCash	201071000	usd
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	230441000	usd
CY2022Q3	pct	Working Capital WorkingCapital	275243000	usd
CY2021Q4	pct	Working Capital WorkingCapital	306890000	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-233163000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-157779000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-75384000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-58110000	usd
CY2022Q3	pct	Available Unrestricted Liquidity Amount AvailableUnrestrictedLiquidityAmount	160400000	usd
CY2022Q3	pct	Other Facility Set Aside Amount OtherFacilitySetAsideAmount	54600000	usd
CY2022Q3	pct	Additional Operational Reserves AdditionalOperationalReserves	4600000	usd
CY2022Q3	pct	Additional Facility Construction Costs AdditionalFacilityConstructionCosts	75000000	usd
CY2022Q3	pct	Additional Facility Construction Costs Construction Performance Guarantee AdditionalFacilityConstructionCostsConstructionPerformanceGuarantee	12000000	usd
CY2022Q3	pct	Other Net Capital Commitments OtherNetCapitalCommitments	8600000	usd
CY2022Q3	pct	Other Net Capital Commitments OtherNetCapitalCommitments	8600000	usd
CY2022Q3	pct	Common Stock Number Of Votes For Each Share Held CommonStockNumberOfVotesForEachShareHeld	1	vote
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	163510000	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	163510000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	127650000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	127650000	shares
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	0	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	613000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	28900
	pct	Share Based Compensation Arrangement By Share Based Payment Award Options Granted Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm	P7Y
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	613000	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	28900
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y5M15D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	613000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	28900
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y2M15D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	118255000	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	118255000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	153513000	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	613000	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	28900
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y3M18D
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	613000	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	11.41
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2021Q1	pct	Class Of Warrant Or Right Redemption Price Of Warrants Or Rights ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights	0.01
CY2021Q1	pct	Class Of Warrant Or Right Redemption Of Warrants Or Rights Written Notice Of Redemption Threshold ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsWrittenNoticeOfRedemptionThreshold	P30D
CY2021Q1	pct	Derivative Instrument Contingent Consideration Liability Earnout Period Stock Price Trigger DerivativeInstrumentContingentConsiderationLiabilityEarnoutPeriodStockPriceTrigger	18.00
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5081000	usd
CY2021Q1	pct	Derivative Instrument Contingent Consideration Liability Earnout Period Threshold Trading Days DerivativeInstrumentContingentConsiderationLiabilityEarnoutPeriodThresholdTradingDays	20	d
CY2021Q1	pct	Derivative Instrument Contingent Consideration Liability Earnout Period Threshold Trading Day Period DerivativeInstrumentContingentConsiderationLiabilityEarnoutPeriodThresholdTradingDayPeriod	30	d
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-34948000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-34948000	usd
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-20977000	usd
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-20977000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-75384000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-75384000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-58110000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-58110000	usd
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	163490000	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	163490000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	153513000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	95773000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	95773000	shares
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.21
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.21
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.18
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.49
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.49
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.61
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.61
CY2022Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	446197000	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7611000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	438586000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	230295000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	225214000	usd
CY2022Q3	us-gaap	Depreciation Depreciation	900000	usd
CY2021Q3	us-gaap	Depreciation Depreciation	500000	usd
	us-gaap	Depreciation Depreciation	2600000	usd
	us-gaap	Depreciation Depreciation	1500000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q3	us-gaap	Debt Securities Available For Sale Amortized Cost Current DebtSecuritiesAvailableForSaleAmortizedCostCurrent	159536000	usd
CY2022Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	usd
CY2022Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	1023000	usd
CY2022Q3	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	158513000	usd
CY2021Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Current DebtSecuritiesAvailableForSaleAmortizedCostCurrent	167602000	usd
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	usd
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	237000	usd
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	167365000	usd
CY2022Q3	us-gaap	Available For Sale Securities Debt Maturities Next Rolling Twelve Months Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis	147543000	usd
CY2022Q3	us-gaap	Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue	146604000	usd
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities Next Rolling Twelve Months Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis	117164000	usd
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue	117100000	usd
CY2022Q3	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Two Through Five Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis	11993000	usd
CY2022Q3	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Two Through Five Fair Value AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue	11909000	usd
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Two Through Five Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis	50438000	usd
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Two Through Five Fair Value AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue	50265000	usd
CY2022Q3	us-gaap	Debt Securities Available For Sale Amortized Cost Current DebtSecuritiesAvailableForSaleAmortizedCostCurrent	159536000	usd
CY2022Q3	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	158513000	usd
CY2021Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Current DebtSecuritiesAvailableForSaleAmortizedCostCurrent	167602000	usd
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	167365000	usd
	pct	Debt Securities Held To Maturity Weighted Average Remaining Maturity DebtSecuritiesHeldToMaturityWeightedAverageRemainingMaturity	P0Y6M
	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	0	usd
	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	0	usd
CY2021Q2	pct	Loss Contingency Number Of Class Actions LossContingencyNumberOfClassActions	2	classaction
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	12300000	usd
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	12700000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P15Y
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	52300000	usd
CY2022Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	618000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	1390000	usd
CY2022Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	83000	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	291000	usd
CY2022Q3	us-gaap	Lease Cost LeaseCost	701000	usd
	us-gaap	Lease Cost LeaseCost	1681000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	1829000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	8266000	usd
CY2022Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y10M24D
CY2022Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.047
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	19607000	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2197000	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	17126000	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	19323000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	747000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	3065000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	3065000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	3118000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	3038000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	2679000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	7474000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	23186000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	3863000	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	19323000	usd

Files In Submission

Name	View Source	Status
0001830033-22-000059-index-headers.html	Edgar Link	pending
0001830033-22-000059-index.html	Edgar Link	pending
0001830033-22-000059.txt	Edgar Link	pending
0001830033-22-000059-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pct-20220930.htm	Edgar Link	pending
pct-20220930.xsd	Edgar Link	pending
pct-20220930_g1.jpg	Edgar Link	pending
pct-form10xqex311q32022.htm	Edgar Link	pending
pct-form10xqex312q32022.htm	Edgar Link	pending
pct-form10xqex321q32022.htm	Edgar Link	pending
pct-form10xqex322q32022.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
pct-20220930_cal.xml	Edgar Link	unprocessable
pct-20220930_def.xml	Edgar Link	unprocessable
pct-20220930_lab.xml	Edgar Link	unprocessable
pct-20220930_pre.xml	Edgar Link	unprocessable
pct-20220930_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PCT
PureCycle Technologies, Inc. Stock $pct

2022 Q4 Form 10-Q Financial Statement

#000183003322000059 Filed on November 09, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCT PureCycle Technologies, Inc. Stock $pct

2022 Q4 Form 10-Q Financial Statement

#000183003322000059 Filed on November 09, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCT
PureCycle Technologies, Inc. Stock $pct